Financials
- Market Capitalization 198.4 M
- Employee 108
- Founded 2015
- CEO N/A
- Website www.nkartatx.com
- Headquarter Delaware, United States
- FIGI BBG00JXHS9G7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.31
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3619 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 75.13 USD | +3.53% | -5.15% | -10.80% | +256.07% | 209.32 M USD | ||
| 3628 | ARMP Armata Pharmaceuticals, Inc. Common Stock | 5.38 USD | -0.74% | +19.29% | +16.45% | -34.17% | 200.04 M USD | ||
| 3641 | KRRO Korro Bio, Inc. - Common Stock | 13.26 USD | -3.07% | 0.00% | +25.93% | -65.91% | 195.26 M USD | ||
| 3654 | HUMA Humacyte, Inc. - Common Stock | 0.67 USD | -2.90% | -1.47% | +6.35% | -58.39% | 186.12 M USD |